US Regenerative Medicine Market to Grow at a 19.88% CAGR by 2018

According to the ”Regenerative Medicine Market in the US 2014-2018” report the Regenerative Medicine market in the US will grow at a CAGR of 19.88 percent over the period 2013-2018.

Regenerative medicine is the branch of medicine which uses therapeutically induced or laboratory-grown human tissue to treat injured or diseased human cells, tissues, or organs. This branch of medicine focuses on repairing, replacing, or regenerating the damaged cells of the body and thus represents a paradigm shift in healthcare treatment. The two main technologies used in regenerative medicine are tissue engineering and stem cell technology.

Covered in this Report

The Regenerative Medicine market in the US can be divided into 11 segments: Orthopedic Tendon and Ligament, Chronic and Acute Wounds, Cardiology, Plastic and Reconstructive Surgery, Osteoarthritis, Trauma, General Surgery, Hernia Repair, Burns, Urology, and Urogynecology.

Purchase a Copy of this Report Directly at

Regenerative Medicine Market in the US 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. It focuses on the Regenerative Medicine market in the US landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Country


Key Vendors

  • IBM Corp.
  • Oracle Corp.
  • SAP AG
  • SAS Institute Inc.

Inquire Before Buying the Report @

Other Prominent Vendors

  • Aastrom Biosciences Inc.
  • Acologix Inc.
  • Advanced Cell Technology Inc.
  • Arteriocyte Inc.
  • Athersys Inc.
  • Avita Medical Ltd.
  • Bacterin International Inc.
  • Bellicum Pharmaceuticals Inc.
  • Bioactive Regenerative Therapeutics Inc.
  • BioCardia Inc.
  • BioLife Solutions Inc.
  • CryoLife Inc.
  • Cynata Therapeutics Inc.
  • Cytomedix Inc.
  • Cytori Therapeutics Inc.
  • Fibrocell Science Inc.
  • Forticell Bioscience Inc.
  • GE Healthcare
  • Geron Corp.
  • Histogenics
  • Humacyte Inc.
  • Integra Life Sciences Holdings Corp.
  • InVivo Therapeutics
  • Kensey Nash Corp.
  • Kinetic Concepts Inc.
  • MaxCyte Inc.
  • Mesoblast Ltd.
  • Nanofiber Solutions CTO
  • NeoStem Inc.
  • Neuralstem Inc.
  • Olympus Terumo Biomaterials Corp.
  • Opexa Therapeutics Inc.
  • Organogenesis Inc.
  • Osiris Therapeutics Inc.
  • Osteotech Inc.
  • Pluristem Therapeutics Inc.
  • ReNeuron Group plc
  • RTI Biologics Inc.
  • SanBio Inc.
  • StemCells Inc.
  • Tengion Inc.
  • Thermo Fischer Scientific Inc.
  • Tissue Genesis Inc.
  • ViaCyte Inc.

Key Market Driver

  • Increasing Prevalence of Degenerative Diseases

Key Market Challenge

  • Stringent Regulatory Approval Process

Key Market Trend

  • Increase in Mergers and Acquisitions

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?